Lung Diseases, Interstitial
"Lung Diseases, Interstitial" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A diverse group of lung diseases that affect the lung parenchyma. They are characterized by an initial inflammation of PULMONARY ALVEOLI that extends to the interstitium and beyond leading to diffuse PULMONARY FIBROSIS. Interstitial lung diseases are classified by their etiology (known or unknown causes), and radiological-pathological features.
Descriptor ID |
D017563
|
MeSH Number(s) |
C08.381.483
|
Concept/Terms |
Lung Diseases, Interstitial- Lung Diseases, Interstitial
- Interstitial Lung Disease
- Lung Disease, Interstitial
- Interstitial Lung Diseases
- Diffuse Parenchymal Lung Diseases
Pneumonia, Interstitial- Pneumonia, Interstitial
- Interstitial Pneumonia
- Interstitial Pneumonias
- Pneumonias, Interstitial
- Pneumonitis, Interstitial
- Interstitial Pneumonitides
- Interstitial Pneumonitis
- Pneumonitides, Interstitial
|
Below are MeSH descriptors whose meaning is more general than "Lung Diseases, Interstitial".
Below are MeSH descriptors whose meaning is more specific than "Lung Diseases, Interstitial".
This graph shows the total number of publications written about "Lung Diseases, Interstitial" by people in this website by year, and whether "Lung Diseases, Interstitial" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 2 | 0 | 2 | 1997 | 1 | 0 | 1 | 1998 | 1 | 2 | 3 | 1999 | 1 | 1 | 2 | 2000 | 1 | 0 | 1 | 2001 | 1 | 0 | 1 | 2002 | 5 | 0 | 5 | 2003 | 3 | 2 | 5 | 2004 | 4 | 2 | 6 | 2005 | 5 | 2 | 7 | 2006 | 8 | 2 | 10 | 2007 | 10 | 0 | 10 | 2008 | 5 | 0 | 5 | 2009 | 12 | 1 | 13 | 2010 | 8 | 1 | 9 | 2011 | 6 | 1 | 7 | 2012 | 12 | 2 | 14 | 2013 | 19 | 0 | 19 | 2014 | 12 | 1 | 13 | 2015 | 11 | 3 | 14 | 2016 | 14 | 2 | 16 | 2017 | 18 | 1 | 19 | 2018 | 13 | 0 | 13 | 2019 | 25 | 1 | 26 | 2020 | 19 | 1 | 20 | 2021 | 21 | 1 | 22 | 2022 | 29 | 1 | 30 | 2023 | 33 | 0 | 33 | 2024 | 31 | 2 | 33 | 2025 | 5 | 2 | 7 |
To return to the timeline, click here.
Below are the most recent publications written about "Lung Diseases, Interstitial" by people in Profiles.
-
Rose JA, Steele MP, Kosak Lopez EJ, Axelsson GT, Galecio Chao AG, Waich A, Regan K, Gulati S, Maeda AH, Sultana S, Cutting C, Tukpah AC, Synn AJ, Rice MB, Goldberg HJ, Lee JS, Lynch DA, Putman RK, Hatabu H, Raby BA, Schwartz DA, Rosas IO, Hunninghake GM. Protein biomarkers of interstitial lung abnormalities in relatives of patients with pulmonary fibrosis. Eur Respir J. 2025 Jun; 65(6).
-
Wilson TM, Bolt M, Stahly A, Lee JS, Bang TJ, Sachs PB, Deane KD, Humphries SM, Solomon JJ, Demoruelle MK. Transforming growth factor-beta is increased in sputum from individuals with rheumatoid arthritis-associated pulmonary fibrosis. Rheumatology (Oxford). 2025 Jun 01; 64(6):3989-3995.
-
Voss LA, Nevel RJ, Wambach JA, Nogee LM, Deterding RR, Casey AM, O'Connor MG, Craven DI, Taylor JB, Deutsch GH, Tam-Williams JB, Steffes LC, Brennan SK, Santiago MT, Sadreameli SC, Heras AF, Powers MR, Popova AP, Bansal M, Hamvas A, Gower WA, Urrego F, Young LR. Genetic Testing Utilization in the U.S. Registry for Childhood Interstitial and Diffuse Lung Diseases. Pediatr Pulmonol. 2025 Apr; 60(4):e71073.
-
McDermott GC, Moll M, Cho MH, Hayashi K, Juge PA, Doyle TJ, Paudel ML, Kinney GL, Kronzer VL, Kim JS, O'Keeffe LA, Davis NA, Bernstein EJ, Dellaripa PF, Regan EA, Hunninghake GM, Silverman EK, Ash SY, San Jose Estepar R, Washko GR, Sparks JA. Polygenic risk scores for rheumatoid arthritis and idiopathic pulmonary fibrosis and associations with RA, interstitial lung abnormalities, and quantitative interstitial abnormalities among smokers. Semin Arthritis Rheum. 2025 Jun; 72:152708.
-
Moen EV, Prior TS, Kreuter M, Wuyts WA, Molina-Molina M, Wijsenbeek M, Morais A, Tzouvelekis A, Ryerson CJ, Caro F, Buendia-Roldan I, Magnusson JM, Lee JS, Morisett J, Oldham JM, Troy LK, Funke-Chambour M, Alberti ML, Borie R, Walsh SLF, Rajan S, Kondoh Y, Khor YH, Bendstrup E. Diagnosis, screening, and follow-up of patients with familial interstitial lung disease: Results from an international survey. BMC Pulm Med. 2025 Feb 03; 25(1):59.
-
Flack KF, George MD, Kim JS, Hsu JY, Podolanczuk AJ, Hoffman EA, Johnson C, McGroder CF, Smith BM, Kreider M, Kawut SM, Barr RG, Anderson MR, Bernstein EJ. Antinuclear antibodies and progression of quantitative interstitial lung changes: The Multi-Ethnic Study of Atherosclerosis (MESA)-Lung Study. Respir Med. 2025 Mar; 238:107955.
-
McDermott GC, Hayashi K, Yoshida K, Juge PA, Moll M, Cho MH, Doyle TJ, Kinney GL, Dellaripa PF, Wallace ZS, Regan EA, Hunninghake GM, Silverman EK, Ash SY, Estepar RSJ, Washko GR, Sparks JA. Rheumatoid arthritis, quantitative parenchymal lung features and mortality among smokers. Rheumatology (Oxford). 2025 01 01; 64(1):133-142.
-
Song J, Chae KJ, Lee JE, Yanagawa M, Chung JH, Lynch DA, Jang MJ, Goo JM, Yoon SH. Optimizing prone CT use for suspected interstitial lung abnormalities. Eur Radiol. 2025 Jun; 35(6):3021-3029.
-
Rose JA, Tukpah AC, Cutting C, Wada N, Nishino M, Moll M, Kalra S, Choi B, Lynch DA, Raby BA, Rosas IO, San Jos? Est?par R, Washko GR, Silverman EK, Cho MH, Hatabu H, Putman RK, Hunninghake GM. Development, Progression, and Mortality of Suspected Interstitial Lung Disease in COPDGene. Am J Respir Crit Care Med. 2024 Dec 15; 210(12):1453-1460.
-
Salisbury ML, Markin C, Fadely T, Guttentag AR, Humphries SM, Lynch DA, Kropski JA, Blackwell TS. Progressive Early Interstitial Lung Abnormalities in Persons at Risk for Familial Pulmonary Fibrosis: A Prospective Cohort Study. Am J Respir Crit Care Med. 2024 Dec 15; 210(12):1441-1452.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|